Search Results - "Kim, D.W.N"

Extracranial Renal Cell Carcinoma Treated With Stereotactic Ablative Body Radiation Therapy Leads to Excellent Lesional Control by Wang, C.J, Huelsmann, L, Hannan, R, Timmerman, R.D, Meyer, J.J, Abdulrahman, R.E, Nedzi, L.A, Margulis, V, Brugarolas, J, Kim, D.W.N

Get full text

High Presalvage Radiation Therapy Prostate-Specific Antigen Strongly Correlates With Very Early Failure, Which Leads to Worse Outcome by Ying, J, Tumati, V, Yan, J, Xie, X.J, Roehrborn, C, Margulis, V, Pistenmaa, D.A, Hannan, R, Choe, K.S, Kim, D.W.N

Get full text

Early Results of a Phase I Pre-Operative Single Fraction Ablative Trial for Early Stage Breast Cancer by Rahimi, A.S., Leitch, M., Dogan, B., Alluri, P.G., Farr, D., Arbab, M., Seiler, S., Kim, D.W.N., Wooldridge, R., Unni, N., Nwachukwu, C.R., Patel, I., Zhang, Y., Parsons, D.D.M., Nguyen, A., Morgan, H.E., McArthur, H.L., Sahoo, S., Timmerman, R.D.

“…To explore the impact of pre-operative single fraction stereotactic ablative partial breast irradiation (SPBI) dose escalation (30, 34, or 38Gy) on toxicity…”
Get full text

Multi-Institutional Phase 2 Trial of High-Dose Stereotactic Body Radiation Therapy with Temporary Hydrogel Spacer for Low- and Intermediate-Risk Prostate Cancer by Folkert, M.R., Zelefsky, M.J., Hannan, R., Desai, N.B., Lotan, Y., Laine, A.M., Kim, D.W.N., Hardee, S., Hornberger, B., Kollmeier, M.A., McBride, S., Xie, X.J., Roehrborn, C., Timmerman, R.D.

Get full text